Clinical Trial Update: A Phase I/II Study of HE3235 in Patients With Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial of HE3235 in prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• HE3235

Snippet

Sponsor: Harbor Therapeutics | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED